DOI: 10.1055/s-00000054

Pharmacopsychiatry

References

Kishi T, Mukai T, Matsuda Y. et al.
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials.

J Psychiatr Res 2013;
47: 1557-1563

Download Bibliographical Data

Search in:
Access: